Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
UNC5A
is an axon-guidance molecule, and plays a critical role in neuronal development and differentiation as a netrin-1 receptor. Emerging evidence suggests that axon guidance molecules including
UNC5A
regulate apoptosis in non-neuronal cells. Here, we report that
UNC5A
regulates apoptosis as a downstream target of p53.
UNC5A
expression was strongly induced by exogenous and endogenous p53. Chromatin immunoprecipitation (ChIP) revealed that p53 binds to a sequence in the promoter region of the
UNC5A
gene. Reporter assays showed that this sequence exhibits p53-dependent transcriptional activity. Overexpression of
UNC5A
significantly suppressed colony formation of two glioblastoma cell lines-U373MG and T98G.
UNC5A
dramatically induced apoptosis through the activation of caspase-3 in various cancer cell lines, including LS174T (colon cancer), U373MG (glioblastoma), SH-SY5Y (
neuroblastoma
), and SKNAS (
neuroblastoma
). Finally, gamma irradiation strongly induced the expression of
UNC5A
mRNA in the spleen and colon of p53+/+ mice, but not in those of p53-/- mice, implying that the transcription of
UNC5A
in vivo is regulated by p53. These results suggest that
UNC5A
is a novel transcriptional target of p53 and plays a role in p53-dependent apoptosis.
...
PMID:Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis. 2037